Labeling proteins at high specific activity using N-succinimidyl 4-[F-18](fluoromethyl) benzoate

被引:38
作者
Lang, L
Eckelman, WC
机构
[1] Positron Emission Tomography Dept., Warren Grant Magnuson Clin. Center, National Institutes of Health, Bethesda, MD 20892
[2] NIH, Building 10, Bethesda, MD 20892
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0969-8043(96)00151-0
中图分类号
O61 [无机化学];
学科分类号
070301 [无机化学]; 081704 [应用化学];
摘要
High effective specific activity N-succinimidyl 4-[F-18](fluoromethyl)benzoate was prepared using a reversed phase HPLC procedure. Reversed phase HPLC removed several additional impurities not removed by normal phase HPLC, thereby increasing the effective specific activity. Small amount (<100 mu g) of sensitive proteins such as erythropoietin can be labeled with this reagent in high yield without aggregation. Copyright (C) 1997 Published by Elsevier Science Ltd
引用
收藏
页码:169 / 173
页数:5
相关论文
共 16 条
[1]
Aloj L, 1996, J NUCL MED, V37, P1408
[2]
ERYTHROPOIETIN RECEPTOR CHARACTERISTICS ON PRIMARY HUMAN ERYTHROID-CELLS [J].
BROUDY, VC ;
LIN, N ;
BRICE, M ;
NAKAMOTO, B ;
PAPAYANNOPOULOU, T .
BLOOD, 1991, 77 (12) :2583-2590
[3]
CHITAMBAR CR, 1987, CANCER RES, V47, P3929
[4]
CHRETIEN S, 1994, BLOOD, V83, P1813
[5]
THE APPLICATION OF RECEPTOR THEORY TO RECEPTOR-BINDING AND ENZYME-BINDING ONCOLOGIC RADIOPHARMACEUTICALS [J].
ECKELMAN, WC .
NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (05) :759-769
[6]
EQUILIBRIUM-CONSTANTS FOR THE BINDING OF INDIUM(III) TO HUMAN SERUM TRANSFERRIN [J].
HARRIS, WR ;
CHEN, Y ;
WEIN, K .
INORGANIC CHEMISTRY, 1994, 33 (22) :4991-4998
[7]
KREITMAN RJ, 1994, BLOOD, V83, P426
[8]
ONE-STEP SYNTHESIS OF F-18 LABELED [F-18] N-SUCCINIMIDYL 4-(FLUOROMETHYL)BENZOATE FOR PROTEIN LABELING [J].
LANG, LX ;
ECKELMAN, WC .
APPLIED RADIATION AND ISOTOPES, 1994, 45 (12) :1155-1163
[9]
LARSON SM, 1979, J NUCL MED, V20, P837
[10]
LARSON SM, 1980, JNCI-J NATL CANCER I, V64, P41